001. at canadianbusiness.com, Chris MacDonald,
"director of the Jim Pattison Ethical Leadership Program at the Ted Rogers School of Management, and founding co-editor of the Business Ethics Journal Review [..and] co-author (with pharmacist Scott Gavura) of the peer-reviewed article, 'Alternative Medicine and the Ethics of Commerce,' forthcoming in the journal Bioethics",
writes in "Loblaws Selling Homeopathy is Junk Science and Bad Corporate Ethics" (2015-12-15):
"wouldn’t it be shocking if a company promoted a healthcare product that had not just a slim chance of working, but literally no chance at all? [...worth than] lotteries [...more like a] Ponzi scheme [...and] advising people to buy into a Ponzi scheme would be the height of professional irresponsibility for a financial institution [...] here’s a sign that greeted me in the back corner of my local Loblaws supermarket: 'homeopathy has the potential to stimulate the body’s own healing powers. Ask us to help you select a remedy.' The problem here is of course that homeopathy doesn’t work. It cannot work, as a matter of simple biology, and it’s been thoroughly tested and proven not to work. Scientific consensus is clear and unambiguous on this [...] a company the size of Loblaw Cos. Ltd. has no excuse for not knowing this [...] homeopathy is the healthcare equivalent of a Ponzi scheme. Loblaws—and any other retail outlet that sells it—should be ashamed [...]";
hear, hear. And I'll keep my eyes open for that article.